agilon health, inc. Common Stock (AGL)

Shares of healthcare services company Agilon Health (NYSE:AGL) jumped 18% in the afternoon session after the company's fourth-quarter 2025 results showed a mix of positives and negatives that ultimately pleased investors. 

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

agilon health (AGL) Q4 2025 Earnings Transcript

Healthcare services company Agilon Health (NYSE:AGL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 3.1% year on year to $1.57 billion. On the other hand, next quarter’s revenue guidance of $1.37 billion was less impressive, coming in 12.6% below analysts’ estimates. Its GAAP loss of $0.46 per share was 69.1% below analysts’ consensus estimates.

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December 31, 2025.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL) between February 26, 2025 and August 4, 2025, inclusive.

Healthcare services company Agilon Health (NYSE:AGL) will be reporting earnings this Wednesday after the bell. Here’s what investors should know.

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court ruled the previous week that the president could not use the International Emergency Economic Powers Act (IEEPA) for such duties, a decision that had initially sent markets higher. However, the administration invoked a different authority, the Trade Act of 1974, to impose a 15% global tariff for up to 150 days. The rapid reimposition of trade barriers creates significant uncertainty for companies across multiple sectors that depend on international supply chains and global trade. Investors are now weighing the potential impact of these new duties on corporate earnings and broader economic activity.

LOS ANGELES, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK, Feb. 21, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

LOS ANGELES, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the following conferences:

SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL) between February 26, 2025 and August 4, 2025, inclusive.